๐ฌ๐ง We will soon be attending the BAUS North West Urology Meeting in Manchester on 5โ6 February. Donโt miss our session, โ๐๐ฉ๐ฆ ๐๐-๐๐ฏ๐ข๐ฃ๐ญ๐ฆ๐ฅ ๐๐ณ๐ฐ๐ด๐ต๐ข๐ต๐ฆ ๐๐ข๐ฏ๐ค๐ฆ๐ณ ๐๐ข๐ณ๐ฆ ๐๐ข๐ต๐ฉ๐ธ๐ข๐บ: ๐๐ถ๐ณ๐ณ๐ฆ๐ฏ๐ต ๐ข๐ฏ๐ฅ ๐๐ถ๐ต๐ถ๐ณ๐ฆ ๐๐ฆ๐ณ๐ด๐ฑ๐ฆ๐ค๐ต๐ช๐ท๐ฆ๐ด,โ delivered by Sid Singh and Adesina Adesuyi from the George Eliot Hospital NHS Trust. 5th of Feb at 3pm. As the urology community comes together to share innovation, education, and clinical excellence, we invite you to visit Maria Proud , MHA, Business Development Manager at Quibim and Francesca Evans, Clinical Applications Specialist - UK, or book a demo in advance here: https://lnkd.in/ec9Qt8pq. #MedicalImaging #AIinHealthcare #Innovation #ProstateCancer #Urology
We were delighted to take part once again in the annual winter meeting of the Sociรฉtรฉ d'Imagerie Gรฉnito-Urinaire (SIGU) in the French Alps. This third edition featured a dedicated day focused on prostate imaging, bringing together experts to share experiences and discuss best practices in genitourinary imaging. Thank you to everyone who participated in our session โQP-Prostateยฎ โ Optimiser la detection et le suivi du cancer grรขce ร l'IAโ, led by our Business Development Manager in France, Paul Idelson, which sparked valuable insights around the latest advances in AI for prostate imaging. A big thank you to la SIGU, all the speakers, and everyone who joined us and contributed to such engaging and productive exchanges. Weโre proud to be part of a community pushing innovation forward in medical imaging. #SIGU #Radiologie #ImagerieMรฉdicale #JournรฉesDHiver #Radiology #MedicalImaging #ProstateImaging #AIinHealthcare Philippe PUECH, Laurence Rocher, Soizic Baratin Abihanna, Patricia Gutierrez, Raphaรซle Renard Penna, serge brunelle, carole delerue, Michel Dupuis, Thibaut JACQUES, Jerome Prat, BELLIN Marie-France, Claire Palacin
Prostate cancer imaging is entering a new, decisive phase, in which progress is no longer based solely on innovation, but also on consistency, confidence, and clinical impact. In our blog with Dr. Rajan Gupta (Duke University School of Medicine), he explores how imaging biomarkers, radiomics, and AI are transforming prostate MRI by revealing patterns and signs of risk that go far beyond what the human eye can perceive. Innovation is opening the door to more accurate risk stratification and truly personalized imaging, helping standardize prostate MRI across readers and centers. ๐ Read the full conversation: https://bit.ly/49Ots59 #ProstateCancer #MedicalImaging #Radiology #Innovation
We are in Geneva, Switzerland, attending the ๐๐๐ง๐๐ฌ-๐๐ง ๐๐ซ๐จ๐ฌ๐ญ๐๐ญ๐ ๐๐๐ & ๐๐ง๐ญ๐๐ซ๐ฏ๐๐ง๐ญ๐ข๐จ๐ง ๐๐๐ฌ๐ญ๐๐ซ๐๐จ๐ฎ๐ซ๐ฌ๐ 2026, endorsed by ESMRMB and ESUR. Thanks to Kai Vilanova MD, PhD for leading our industry symposium and showcasing QP-Prostate through real-world clinical cases. As a recognized expert in #ProstateCancer diagnosis, he demonstrated how AI is already enabling more accurate and confident detection in clinical practice during the session โ๐๐-๐๐ณ๐ฐ๐ด๐ต๐ข๐ต๐ฆยฎ: ๐๐ฑ๐ต๐ช๐ฎ๐ช๐ป๐ช๐ฏ๐จ ๐๐ข๐ฏ๐ค๐ฆ๐ณ ๐๐ฆ๐ต๐ฆ๐ค๐ต๐ช๐ฐ๐ฏ ๐ธ๐ช๐ต๐ฉ ๐๐ โ ๐๐ฆ๐ท๐ช๐ฆ๐ธ ๐ฐ๐ง ๐๐ญ๐ช๐ฏ๐ช๐ค๐ข๐ญ ๐๐ข๐ด๐ฆ๐ด ๐ข๐ฏ๐ฅ ๐๐น๐ฑ๐ฆ๐ณ๐ต ๐๐ฆ๐ณ๐ด๐ฑ๐ฆ๐ค๐ต๐ช๐ท๐ฆ๐ด.โ We would also like to extend our thanks to the other speakers, distinguished leaders and experts in the diagnosis and treatment of prostate diseases, for their valuable contributions: Dr. Martina Martins, Dr. Francesco Giganti & Dr. stefano regusci. #Radiology #Urology #MedicalImaging
After a median follow-up of 23 years, men who underwent repeated PSA testing showed a 13% lower risk of death from prostate cancer compared to those who were not screened. These landmark results, published in the NEJM Group, provide the strongest long-term evidence to date that PSA testing of the general population produces a sustained reduction in prostate cancer mortality, underscoring the power of early detection to save lives. As healthcare moves toward precision and personalization, robust long-term clinical evidence such as this is essential for designing smarter screening strategies and more effective care pathways that truly improve patient outcomes. https://lnkd.in/dKWucRbb #ProstateCancer #Radiology #Urology #MedicalImaging
In this interview with our investors at Amadeus, our CEO and co-founder, รngel Alberich-Bayarri, explains how artificial intelligence is transforming medical imaging, moving from visual interpretation to becoming a driver of precision health. The conversation also delves into patient-centered healthcare, building trust in a regulated healthcare technology, and the resilience behind scaling bold innovations with the help of key partners. Full video & interview: https://lnkd.in/eXsMMhM8
Conversaciones como la que Pablo Tallรณn Ojeda mantuvo en Cadena SER con nuestro CEO y cofundador, รngel Alberich-Bayarri, demuestran que la innovaciรณn biomรฉdica ya forma parte del debate pรบblico. La inteligencia artificial nos permite ir mรกs allรก de lo que alcanza el ojo humano, identificar patrones clave y avanzar hacia diagnรณsticos mรกs precisos. Un avance que transforma la forma en que entendemos la salud, orientรกndola hacia un enfoque cada vez mรกs predictivo. ๐๏ธ Entrevista completa: https://lnkd.in/e8qT2F9E #Innovacion #IAenSalud
Our latest multicenter study related to QP-Liver evaluated the actual impact of including or excluding hepatic vessels in the automated PDFF and R2* liver quantification in magnetic resonance imaging. ๐ Why it matters: fat faction and iron concentration are key non-invasive biomarkers in chronic liver disease. Robust, reliable imaging biomarkers mean better research reproducibility and greater trust in AI-driven tools for clinical decision-makingโultimately supporting better patient outcomes. Read the full publication here: https://bit.ly/4pyzWLg #LiverImaging #ChronicLiverDisease #MedicalImaging #ImagingBiomarkers #AIinHealthcare
As we enter the final week of 2025, we are celebrating a year of meaningful progress. We are proud of the milestones achieved in our commitment to advance precision health and extend our sincere gratitude to our customers, providers, and research partners. Your collaboration and trust have made this success possible.
Happy Holidays from all of us at Quibim ๐ This year, weโre celebrating the season through the eyes of our youngest creatives, who shared their holiday spirit in drawings inspired by Quibim. We hope you enjoy these special moments with your loved ones, and we extend our heartfelt thanks to all #healthcare professionals and patients whose commitment, resilience, and support inspire us every day. #HappyHolidays
